molnupiravir

Pharmacies start selling first coronavirus drug in Egypt
Egypt

Pharmacies start selling first coronavirus drug in Egypt

Pharmacies in Egypt started receiving shipments of the first drug to treat the coronavirus, on Tuesday, local media reported. The…
Molnupiravir antiviral drug to be provided in Egypt’s government pharmacies
Egypt

Molnupiravir antiviral drug to be provided in Egypt’s government pharmacies

Egypt’s Minister of Higher Education and Scientific Research and Acting Minister of Health Khaled Abdel Ghaffar announced during a Wednesday…
Cabinet denies spread of deadly fraudulent drugs in pharmacies
Egypt

Cabinet denies spread of deadly fraudulent drugs in pharmacies

On Wednesday, the Cabinet Media Center denied the news circulated by some websites and social media pages regarding the spread…
Egypt begins treating COVID-19 patients with new protocol
Egypt

Egypt begins treating COVID-19 patients with new protocol

The Scientific Committee to Combat the Coronavirus at Egypt’s Ministry of Health and Population has amended the treatment protocol for…
Egypt approves use of oral coronavirus drug ‘Molnupiravir’
Egypt

Egypt approves use of oral coronavirus drug ‘Molnupiravir’

The Egyptian Drug Authority announced granting an emergency use license for the “Molnupiravir” drug, after passing the necessary assessments to…
France cancels order for Merck’s COVID-19 antiviral drug
World

France cancels order for Merck’s COVID-19 antiviral drug

PARIS/MILAN, Dec 22 (Reuters) – France has cancelled its order for Merck & Co’s (MRK.N) COVID-19 antiviral drug following disappointing trial data…
Merck co. applies for emergency use of its new anti-coronavirus pills
Science

Merck co. applies for emergency use of its new anti-coronavirus pills

The Merck pharmaceutical company announced that it has applied to US drug authorities and other regulatory agencies around the world…
German, American companies’ COVID-19 drug shows promising results
Health & Fitness

German, American companies’ COVID-19 drug shows promising results

German pharmaceutical company Merck, and US-based Ridgeback Biotherapeutics announced this week promising results from the second phase trials of of an…
Back to top button